Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is more common in men, linked to genetics and androgen levels, but routine pelvic ultrasound isn't recommended.

Hirsutism is relatively common among young Greek women.

Androgenetic alopecia negatively affects emotions and self-confidence, especially in younger people.

Family history affects hair loss severity and onset more in men than women.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Both hair transplantation and skin expansion are effective for treating cicatricial alopecia, with the best method depending on the patient's age, alopecia size, and other factors.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

A woman developed male characteristics after using unregulated hormone therapy.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

New treatments for male hypogonadism are effective and should be personalized.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Medical care for transgender youth should be individualized and supportive.